Sham | Sham + Oxo | NX | NX + Oxo | |
---|---|---|---|---|
Systolic blood pressure | ||||
Week 3 (before treatment) | 119 ± 4 | 120 ± 5 | 128 ± 5 | 127 ± 5 |
Week 12 | 133 ± 7 | 135 ± 5 | 141 ± 6‡ | 151 ± 5‡ |
Body weight (g) | ||||
Week 3 | 341 ± 6 | 337 ± 8 | 335 ± 8 | 331 ± 7 |
Week 12 | 436 ± 9 | 411 ± 12# | 452 ± 11 | 412 ± 30# |
Heart weight (g/kg) at the end of study | ||||
Right ventricle | 0.28 ± 0.01 | 0.29 ± 0.01 | 0.34 ± 0.03‡ | 0.33 ± 0.03‡ |
Left ventricle | 1.71 ± 0.06 | 1.86 ± 0.06 | 2.23 ± 0.11*‡ | 2.41 ± 0.18*‡ |
Removed kidney tissue (g/kg) | 7.67 ± 0.17 | 7.50 ± 0.08 | ||
Uric acid (μmol/l) | 33.5 ± 11.8 | 121.6 ± 22.4* | 64.4 ± 21.0 | 156.7 ± 20.2*† |
Creatinine (μmol/l) | 40.1 ± 5.7 | 49.3 ± 3.2 | 80.7 ± 3.2*‡ | 81.8 ± 8.8*‡ |
Urea (mmol/l) | 6.5 ± 0.4 | 8.3 ± 0.5 | 12.9 ± 0.6*‡ | 14.3 ± 2.2*‡ |